| Medical and Health Sciences | Lifetime | 272 | US 146 | 99.99 |
| Biological Sciences | Lifetime | 371 | US 218 | 99.95 |
| Clinical Neurology | Lifetime | 5 | US 3 | 99.98 |
| Neuroscience of Neurology | Lifetime | 21 | US 7 | 99.82 |
| Cognitive Neuroscience | Lifetime | 94 | US 50 | 99.81 |
| Biomedical Engineering | Lifetime | 429 | US 129 | 99.40 |
| Psychiatry and Mental health | Lifetime | 218 | US 108 | 99.35 |
| Cellular and Molecular Neuroscience | Lifetime | 215 | US 123 | 99.26 |
| Rheumatology | Lifetime | 246 | US 108 | 99.01 |
| Rehabilitation | Lifetime | 302 | US 122 | 96.27 |
| Clinical Neurology | 2021-2025 | 29 | US 8 | 99.38 |
| Psychiatry and Mental health | 2021-2025 | 100 | US 32 | 98.34 |
| Cellular and Molecular Neuroscience | 2021-2025 | 143 | US 64 | 89.98 |
| Cognitive Neuroscience | 2021-2025 | 428 | US 178 | 92.14 |
| Neuroscience of Neurology | 2021-2025 | 176 | US 54 | 90.21 |
| Botulinum Toxin and Related Neurological Disorders | Lifetime | 3 | US 2 | 99.98 |
| Neuromodulation and Treatments for Neurological Disorders | Lifetime | 4 | US 2 | 99.97 |
| Genetic Neurodegenerative Diseases | Lifetime | 4 | US 2 | 99.92 |
| EEG and Brain-Computer Interfaces | Lifetime | 11 | US 4 | 99.90 |
| Glycogen Storage Diseases and Myoclonus | Lifetime | 3 | US 2 | 99.89 |
| Transcranial Magnetic Stimulation Studies | Lifetime | 8 | US 4 | 99.92 |
| Parkinson's Disease Mechanisms and Treatments | Lifetime | 26 | US 11 | 99.87 |
| Motor Control and Adaptation | Lifetime | 9 | US 5 | 99.77 |
| Muscle activation and electromyography studies | Lifetime | 23 | US 9 | 99.77 |
| Psychosomatic Disorders and Their Treatments | Lifetime | 15 | US 7 | 99.76 |
| Neuroscience and Neural Engineering | Lifetime | 95 | US 51 | 99.43 |
| Vestibular and auditory disorders | Lifetime | 72 | US 32 | 99.13 |
| Neurology and Historical Studies | Lifetime | 19 | US 5 | 98.27 |
| Autoimmune Neurological Disorders and Treatments | Lifetime | 31 | US 13 | 98.64 |
| Functional Brain Connectivity Studies | Lifetime | 313 | US 153 | 99.17 |
| Neurological and metabolic disorders | Lifetime | 85 | US 42 | 97.77 |
| Obsessive-Compulsive Spectrum Disorders | Lifetime | 128 | US 80 | 98.60 |
| Action Observation and Synchronization | Lifetime | 163 | US 57 | 97.63 |
| Ophthalmology and Eye Disorders | Lifetime | 301 | US 140 | 97.28 |
| Cerebral Palsy and Movement Disorders | Lifetime | 539 | US 191 | 97.24 |
| Hereditary Neurological Disorders | Lifetime | 163 | US 57 | 97.04 |
| Neural dynamics and brain function | Lifetime | 873 | US 401 | 97.89 |
| Advanced Neuroimaging Techniques and Applications | Lifetime | 867 | US 381 | 96.87 |
| Mental Health and Psychiatry | Lifetime | 545 | US 225 | 96.02 |
| Parkinson's Disease and Spinal Disorders | Lifetime | 151 | US 64 | 93.40 |
| Peripheral Nerve Disorders | Lifetime | 751 | US 304 | 92.72 |
| Facial Nerve Paralysis Treatment and Research | Lifetime | 951 | US 398 | 89.82 |
| Musicians’ Health and Performance | Lifetime | 143 | US 37 | 87.01 |
| Free Will and Agency | Lifetime | 224 | US 112 | 88.26 |
| Trigeminal Neuralgia and Treatments | Lifetime | 915 | US 306 | 87.08 |
| Hemispheric Asymmetry in Neuroscience | Lifetime | 876 | US 344 | 81.18 |
| Botulinum Toxin and Related Neurological Disorders | 2021-2025 | 8 | US 2 | 98.91 |
| Genetic Neurodegenerative Diseases | 2021-2025 | 11 | US 3 | 98.70 |
| Neuromodulation and Treatments for Neurological Disorders | 2021-2025 | 18 | US 7 | 99.45 |
| Psychosomatic Disorders and Their Treatments | 2021-2025 | 13 | US 5 | 98.49 |
| Parkinson's Disease Mechanisms and Treatments | 2021-2025 | 111 | US 31 | 98.20 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | 2021-2025 | 160 | US 42 | 93.18 |
| Glycogen Storage Diseases and Myoclonus | 2021-2025 | 36 | US 9 | 93.52 |
| Transcranial Magnetic Stimulation Studies | 2021-2025 | 179 | US 48 | 94.23 |
| Vestibular and auditory disorders | 2021-2025 | 465 | US 90 | 85.63 |
| Mental Health and Psychiatry | 2021-2025 | 508 | US 116 | 77.01 |
| Obsessive-Compulsive Spectrum Disorders | 2021-2025 | 670 | US 188 | 78.52 |
| Neurological and metabolic disorders | 2021-2025 | 240 | US 50 | 68.93 |
| Motor Control and Adaptation | 2021-2025 | 651 | US 148 | 69.71 |